RPGLIFE Stock Overview
RPG Life Sciences Limited, empresa farmacéutica integrada, desarrolla, fabrica y comercializa formulaciones de marca, genéricas e ingredientes farmacéuticos activos (API) sintéticos en India y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
RPG Life Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,576.60 |
| 52 Week High | ₹1,740.00 |
| 52 Week Low | ₹726.50 |
| Beta | 0.49 |
| 1 Month Change | 3.54% |
| 3 Month Change | 11.86% |
| 1 Year Change | 110.94% |
| 3 Year Change | 290.15% |
| 5 Year Change | 524.03% |
| Change since IPO | 3,411.36% |
Recent News & Updates
Recent updates
RPG Life Sciences (NSE:RPGLIFE) Is Increasing Its Dividend To ₹12.00
Jul 11
Estimating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Sep 05Shareholders May Be More Conservative With RPG Life Sciences Limited's (NSE:RPGLIFE) CEO Compensation For Now
Aug 24A Look At The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Jun 14Are Strong Financial Prospects The Force That Is Driving The Momentum In RPG Life Sciences Limited's NSE:RPGLIFE) Stock?
Feb 09Can You Imagine How RPG Life Sciences' (NSE:RPGLIFE) Shareholders Feel About The 75% Share Price Increase?
Jan 13RPG Life Sciences (NSE:RPGLIFE) Is Growing Earnings But Are They A Good Guide?
Dec 23
Declining Stock and Solid Fundamentals: Is The Market Wrong About RPG Life Sciences Limited (NSE:RPGLIFE)?
Nov 11Estimating The Fair Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Oct 21Did Business Growth Power RPG Life Sciences' (NSE:RPGLIFE) Share Price Gain of 126%?
Sep 28What Makes RPG Life Sciences Limited (NSE:RPGLIFE) A Great Dividend Stock?
Aug 31With RPG Life Sciences Limited (NSE:RPGLIFE) It Looks Like You'll Get What You Pay For
Aug 11What You Can Learn From RPG Life Sciences Limited's (NSE:RPGLIFE) P/E
Jul 28Calculating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Jul 10Shareholder Returns
| RPGLIFE | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 3.2% | 0.7% | 2.9% |
| 1Y | 110.9% | 61.9% | 48.5% |
Rentabilidad frente al sector: RPGLIFE superó al sector Indian Pharmaceuticals , que obtuvo un rendimiento del 65.4% el año pasado.
Rentabilidad vs. Mercado: RPGLIFE superó al mercado Indian, que obtuvo un rendimiento del 44.7% el año pasado.
Price Volatility
| RPGLIFE volatility | |
|---|---|
| RPGLIFE Average Weekly Movement | 4.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.3% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: RPGLIFE no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de RPGLIFE (5%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 1,214 | Yugal Kishor Sikri | https://www.rpglifesciences.com |
RPG Life Sciences Limited, una empresa farmacéutica integrada, desarrolla, fabrica y comercializa formulaciones de marca, genéricas e ingredientes farmacéuticos activos (API) sintéticos en India y a escala internacional. La empresa ofrece API sintéticos en diversas categorías terapéuticas, como inmunosupresores, antipsicóticos, antianginosos, antihelmínticos, anticonvulsivos, antiespasmódicos, etc. Suministra genéricos principalmente en el área de la terapia inmunosupresora; y formulaciones de dosificación acabadas para diversas terapias. Opera en nefrología, reumatología, oncología, gastroenterología, cardiovascular, ortopedia, respiratorio, neurología, general, urología, antidiabético, antidengue, vitaminas y minerales, ginecología, pediatría, etc. La empresa era conocida anteriormente como RPG Pharmaceuticals Limited y cambió su nombre por RPG Life Sciences Limited en febrero de 2008.
RPG Life Sciences Limited Fundamentals Summary
| RPGLIFE fundamental statistics | |
|---|---|
| Market cap | ₹26.08b |
| Earnings (TTM) | ₹847.70m |
| Revenue (TTM) | ₹5.74b |
30.8x
P/E Ratio4.5x
P/S RatioIs RPGLIFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RPGLIFE income statement (TTM) | |
|---|---|
| Revenue | ₹5.74b |
| Cost of Revenue | ₹1.88b |
| Gross Profit | ₹3.86b |
| Other Expenses | ₹3.01b |
| Earnings | ₹847.70m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 51.25 |
| Gross Margin | 67.31% |
| Net Profit Margin | 14.78% |
| Debt/Equity Ratio | 0% |
How did RPGLIFE perform over the long term?
See historical performance and comparison